
Ubiquitination
Ubiquitination inhibitors are compounds that interfere with the process of ubiquitination, where proteins are tagged with ubiquitin molecules for degradation by the proteasome. These inhibitors are critical for studying protein turnover, signal transduction, and the regulation of various cellular processes. Ubiquitination plays a key role in many diseases, including cancer, neurodegenerative disorders, and immune system dysfunction. By modulating ubiquitination, these inhibitors can provide insights into the mechanisms of disease and open up new avenues for therapeutic intervention. At CymitQuimica, we offer a wide selection of high-quality ubiquitination inhibitors to support your research in cell biology, proteomics, and drug discovery.
Subcategories of "Ubiquitination"
Found 69 products for "Ubiquitination".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Cbl-b-IN-11
CAS:Cbl-b-IN-11 (Compound 466) is an inhibitor of both casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl, exhibiting half-maximal inhibitory concentrations (IC50s) ofFormula:C31H35F5N6OPurity:98%Color and Shape:SolidMolecular weight:602.64EA-B2L
CAS:EA-B2L is an effective degrader of glutathione S-transferase (GSTP) with a DC50 of 48 μM. It is composed of Ethacrynic acid linked to Boc2Lys. EA-B2L plays a significant role in cancer research.Formula:C35H54Cl2N4O8Color and Shape:SolidMolecular weight:729.73p97-IN-1
CAS:p97-IN-1 is an orally active inhibitor of p97 with an IC50 of 26 nM. It significantly impedes the proliferation of tumor cells and is applicable for research in acute myeloid leukemia (AML).Formula:C25H26N6O2Color and Shape:SolidMolecular weight:442.51Cbl-b-IN-26
CAS:Cbl-b-IN-26 (Example A1) is an inhibitor of Cbl-b with a dissociation constant (Kd) of 34.6 nM. It is used in the research of chronic viral infections and cancer.Formula:C21H19F3N6Color and Shape:SolidMolecular weight:412.41BC-1293
CAS:BC-1293 inhibits FBXO24, stabilizes DARS2, and elevates cytokines in mice, showing immunostimulatory potential for immune modulation research.Formula:C26H28N4O4SPurity:98.40%Color and Shape:White SolidMolecular weight:492.59NSC20116
CAS:NSC20116 is a uracil derivative that specifically targets the Set-and-Ring (SRA) domain of the oncogene UHRF1. It binds to the 5-methylcytosine (5mC) recognition pocket within the UHRF1SRA domain, with a dissociation constant (Kd) of 362 nM. NSC20116 is applicable for cancer research.Formula:C4H4N4O3Molecular weight:156.1PRC1-IN-1
CAS:PRC1-IN-1 (compound RB-4) is an inhibitor of the polycomb repressive complex 1 (PRC1) with an IC50 of 2.3 μM. It targets RING1B-BMI1, RING1A-BMI1, and RING1B-PCGF1, exhibiting IC50 values of 2.8 μM, 2.6 μM, and 1.8 μM, respectively.Formula:C24H19ClFN3O2Color and Shape:SolidMolecular weight:435.878Yucasin
CAS:Yucasin is a highly potent inhibitor of auxin (IAA) biosynthesis that blocks the tryptophan-dependent pathway by specifically inhibiting the activity of YUCCA.Formula:C8H6ClN3SPurity:95.10%Color and Shape:White SolidMolecular weight:211.67Cbl-b-IN-3
CAS:Cbl-b-IN-3 is a potent inhibitor of casitas b lineage lymphoma proto-oncogene-b (Cbl-b) (ic50 < 1 nM).Cost-effective and quality-assured.Formula:C30H34F3N5OPurity:97.63%Color and Shape:Yellow SolidMolecular weight:537.62Ref: TM-T63790
1mg66.00€5mg145.00€1mL*10mM (DMSO)172.00€10mg192.00€25mg364.00€50mg558.00€100mg893.00€

